Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

The reply.

Bruce RD, Beletsky L, Stancliff S, Bowman S.

Am J Med. 2013 Nov;126(11):e21-2. doi: 10.1016/j.amjmed.2013.07.020. No abstract available.

PMID:
24157295
2.

The reply.

Bruce RD, Beletsky L, Stancliff S.

Am J Med. 2013 Nov;126(11):e17. doi: 10.1016/j.amjmed.2013.08.003. No abstract available.

PMID:
24157293
3.

Comments on reducing the health consequences of opioid addiction.

Keller DL.

Am J Med. 2013 Nov;126(11):e19. doi: 10.1016/j.amjmed.2013.05.027. No abstract available.

PMID:
24157294
4.

Screening and brief intervention for opioid addiction in primary care is not evidence based.

Saitz R.

Am J Med. 2013 Nov;126(11):e15. doi: 10.1016/j.amjmed.2013.07.028. No abstract available.

PMID:
24157292
5.

Reducing the health consequences of opioid addiction in primary care.

Bowman S, Eiserman J, Beletsky L, Stancliff S, Bruce RD.

Am J Med. 2013 Jul;126(7):565-71. doi: 10.1016/j.amjmed.2012.11.031. Epub 2013 May 8. Review.

PMID:
23664112
6.

Urine Spiking in a Pain Medicine Clinic: An Attempt to Simulate Adherence.

Lee D, Bazydlo LA, Reisfield GM, Goldberger BA.

Pain Med. 2015 Jul;16(7):1449-51. doi: 10.1111/pme.12663. Epub 2014 Dec 18. No abstract available.

PMID:
25522892
7.

The risk of tramadol abuse and dependence: findings in two patients.

Stoehr JD, Essary AC, Ou C, Ashby R, Sucher M.

JAAPA. 2009 Jul;22(7):31-2, 34-5. No abstract available.

PMID:
19697569
8.

Management of opioid painkiller dependence in primary care: ongoing recovery with buprenorphine/naloxone.

Hard B.

BMJ Case Rep. 2014 Nov 28;2014. pii: bcr2014207308. doi: 10.1136/bcr-2014-207308. Review.

9.

Short answer question case series: the perils of urine toxicology testing.

Graubard M, Rohdenberg P, Jang T.

Emerg Med J. 2011 Nov;28(11):998-9. doi: 10.1136/emermed-2011-200276. Epub 2011 Jun 27. No abstract available.

PMID:
21708959
10.
11.

Office-based treatment of opiate addiction.

Heit HA, Gourlay DL.

N Engl J Med. 2003 Dec 25;349(26):2567-8; author reply 2567-8. No abstract available.

12.

Opioid dependence: rationale for and efficacy of existing and new treatments.

Fiellin DA, Friedland GH, Gourevitch MN.

Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S173-7. Review.

PMID:
17109303
13.

Overdose prevention: naloxone with long acting opioids.

Bowman S, McKenzie M, Rich J.

Med Health R I. 2008 Sep;91(9):271-2. No abstract available.

PMID:
18834043
14.

The changing face of opioid addiction: prescription pain pill dependence and treatment.

Byrne MH, Lander L, Ferris M.

Health Soc Work. 2009 Feb;34(1):53-6. No abstract available.

PMID:
19281102
15.

Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings.

Mintzer IL, Eisenberg M, Terra M, MacVane C, Himmelstein DU, Woolhandler S.

Ann Fam Med. 2007 Mar-Apr;5(2):146-50.

16.

Use and misuse of opioid replacement therapies: a Queensland study.

Smirnov A, Kemp R.

Subst Use Misuse. 2012 Jan;47(1):78-85. doi: 10.3109/10826084.2011.629017.

PMID:
22216993
17.

Opioids and deaths.

Rich JD, Green TC, McKenzie MS.

N Engl J Med. 2011 Feb 17;364(7):686. doi: 10.1056/NEJMc1014490#SA1. No abstract available.

PMID:
21323559
18.

Prescription opioid abuse, chronic pain, and primary care: a Co-occurring Disorders Clinic in the chronic disease model.

Pade PA, Cardon KE, Hoffman RM, Geppert CM.

J Subst Abuse Treat. 2012 Dec;43(4):446-50. doi: 10.1016/j.jsat.2012.08.010. Epub 2012 Sep 11.

PMID:
22980449
19.

Naloxone treatment in opioid addiction: the risks and benefits.

van Dorp E, Yassen A, Dahan A.

Expert Opin Drug Saf. 2007 Mar;6(2):125-32. Review.

PMID:
17367258
20.

An opioid screening instrument: long-term evaluation of the utility of the pain medication questionnaire by Holmes et al.

Passik SD, Kirsh KL.

Pain Pract. 2006 Jun;6(2):69-71. No abstract available.

PMID:
17309712

Supplemental Content

Support Center